1  208 consecutive biopsy-proven patients with primary amyloidosis.

2 as compared with colchicine in patients with primary amyloidosis.

3 ive heart failure (CHF) in patients with AL (primary) amyloidosis.

4                                Patients with primary amyloidosis (AL type) have a poor prognosis, in

5                                              Primary amyloidosis (AL) results from overproduction of

6 A and IgG MGUS progress to multiple myeloma, primary amyloidosis (AL), or a related plasma cell disor

7 Cs) are the precursors of amyloid fibrils in primary amyloidosis (AL).

8 al benefit in the treatment of patients with primary amyloidosis and other acquired or inherited amyl

9 patients with cardiac involvement due to AL (primary) amyloidosis and to evaluate the prognostic impl

10 lobulinemia (WM) requiring treatment, one to primary amyloidosis, and one to lymphoma (total, 75%).

11 had MGRS lesions with amyloid light chain or primary amyloidosis being the most common lesion in 38 p

12 ilure remains the greatest cause of death in primary amyloidosis, due to the development of a rapidly

13                                              Primary amyloidosis has a poor prognosis as a result of

14 aldenstrom macroglobulinemia in 6 (RR, 262), primary amyloidosis in 3 (RR, 16.3), and chronic lymphoc

15                       Seventeen patients had primary amyloidosis, including 5 with Sjogren syndrome,

16                                              Primary amyloidosis is a systemic disorder characterized

17  patients to multiple myeloma, IgM lymphoma, primary amyloidosis, macroglobulinemia, chronic lymphocy

18 ) amyloids, which are associated with AD and primary amyloidosis, respectively.

19        In tissue sections from patients with primary amyloidosis, we also observed the co-localizatio